Avanos Medical, Inc.

AVNS · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$392-$62$51$5
Dep. & Amort.$46$46$48$38
Deferred Tax$0$0$0-$3
Stock-Based Comp.$14$16$16$13
Change in WC$35-$18-$24$26
Other Non-Cash$399$50$1$8
Operating Cash Flow$101$32$91$87
Investing Activities
PP&E Inv.-$18-$18-$19-$21
Net Acquisitions-$10$39-$116$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$28$22-$135-$21
Financing Activities
Debt Repay.-$34-$65$103-$50
Stock Issued$0$0$0$0
Stock Repurch.-$13-$19-$46-$12
Dividends Paid$0$0$0$0
Other Fin. Act.-$3-$10-$1$6
Financing Cash Flow-$49-$94$57-$55
Forex Effect-$4$0-$3-$4
Net Chg. in Cash$20-$40$9$7
Supplemental Information
Beg. Cash$88$128$119$112
End Cash$108$88$128$119
Free Cash Flow$83$15$72$66